Femtobiomed Inc. (XKON:327610)
South Korea
· Delayed Price · Currency is KRW
4,350.00
-70.00 (-1.58%)
At close: Aug 12, 2025, 3:30 PM KST
Femtobiomed Income Statement
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
| FY 2018 | FY 2017 |
| Dec '18 Dec 31, 2018 | Dec '17 Dec 31, 2017 |
| Operating Revenue | 389.95 | 395.57 |
| Other Revenue | 0 | - |
| Revenue | 389.96 | 395.57 |
| Revenue Growth (YoY) | -1.42% | - |
| Cost of Revenue | 270.88 | 252.88 |
| Gross Profit | 119.08 | 142.69 |
| Selling, General & Admin | 776.42 | 692.75 |
| Research & Development | 470.74 | 411.09 |
| Other Operating Expenses | 28.44 | 30.67 |
| Operating Expenses | 1,319 | 1,189 |
| Operating Income | -1,200 | -1,047 |
| Interest Expense | -0.71 | -2.39 |
| Interest & Investment Income | 3.78 | 8.66 |
| Currency Exchange Gain (Loss) | 0.9 | -3.32 |
| Other Non Operating Income (Expenses) | -13.93 | -27.84 |
| EBT Excluding Unusual Items | -1,210 | -1,072 |
| Gain (Loss) on Sale of Assets | - | 1.63 |
| Pretax Income | -1,210 | -1,070 |
| Net Income | -1,210 | -1,070 |
| Net Income to Common | -1,210 | -1,070 |
| Shares Outstanding (Basic) | 1 | 1 |
| Shares Outstanding (Diluted) | 1 | 1 |
| Shares Change (YoY) | 0.06% | - |
| EPS (Basic) | -876.00 | -775.00 |
| EPS (Diluted) | -876.00 | -775.00 |
| Free Cash Flow | -1,233 | -996.14 |
| Free Cash Flow Per Share | -892.82 | -721.51 |
| Gross Margin | 30.54% | 36.07% |
| Operating Margin | -307.76% | -264.62% |
| Profit Margin | -310.32% | -270.50% |
| Free Cash Flow Margin | -316.28% | -251.83% |
| EBITDA | -1,075 | -904.97 |
| EBITDA Margin | -275.77% | -228.78% |
| D&A For EBITDA | 124.75 | 141.76 |
| EBIT | -1,200 | -1,047 |
| EBIT Margin | - | -264.62% |
| Advertising Expenses | 11.23 | 10.08 |
Source: S&P Global Market Intelligence. Standard template.
Financial Sources.